Omeros | OMER - DÍVIDA





DÍVIDA Alterar Data
Adma Biologics USD 83.12M 702K 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Cytokinetics USD 1.2B 338.79M 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Immunic USD 0 0 2024-06
Insmed USD 727.89M 163.33M 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
MacroGenics USD 37.01M 238K 2025-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 60.85B 78M 2025-09
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Xoma USD 120.79M 3.27M 2024-06